<< Read Full Article
<< Read Full Article
Valeant Parkinson's Drug Cleared
Valeant Pharmaceuticals (VRX Quote) said Thursday it has received U.S. clearance to begin marketing a treatment for Parkinson's disease.
The Food and Drug Administration's endorsement of the drug Zelapar concludes a protracted process for Valeant, who submitted the drug for approval in April 2002.
Zelapar helps relieve symptoms of Parkinsons's, a progressive neurological disorder. The FDA approved the once-daily tablet as an adjunct therapy in patients receiving stronger drugs, levodopa or carbidopa. Zelapar will be used by patients who respond poorly to these drugs, helping them during the day when the other drugs wear off. ...
Recent Comments
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,309.92 | 1,091.49 | 2,138.44 | 32.31 |
Oil *
77.12
|
|
DOWN
154.48
|
DOWN
19.14
|
DOWN
37.61
|
DOWN
0.48
|
10 Yr
3.23%
SPDR Gold
115.06
|
|
-1.48%
|
-1.72%
|
-1.73%
|
-1.46%
|
Data delayed 20 minutes |
Connect with TheStreet